Publication | Open Access
ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents
311
Citations
179
References
2018
Year
Metabolic SyndromeDiabetes ManagementGlibenclamide-glyburide SuspensionHealth PolicyBiochemistryMedicineInsulin ManagementDiabetesGlycobiologyPediatricsEuropean UnionPediatric EndocrinologyMonogenic DiabetesDiabetes MellitusScientific AdvisorPharmacologyDrug Discovery
M.P. has acted as scientific advisor for the development of the glibenclamide-glyburide suspension named AMGLIDIA in the European Union. The other authors have declared no conflicts of interest.
| Year | Citations | |
|---|---|---|
Page 1
Page 1